Literature DB >> 12639530

Audit of a policy of magnetic resonance imaging with diffusion-weighted imaging as first-line neuroimaging for in-patients with clinically suspected acute stroke.

B T Buckley1, A Wainwright, T Meagher, D Briley.   

Abstract

AIM: To audit the feasibility and use of diffusion-weighted (DW) magnetic resonance imaging (MRI) as initial neuroimaging for in-patients with clinically suspected acute stroke.
MATERIALS AND METHODS: In April 2000, MRI with DW and T2-weighted sequence was locally instituted as initial neuroimaging for patients with clinically suspected acute stroke. This retrospective study reviewed imaging performed for in-patients with suspected acute stroke over a 9-month period. Data were collected on image type, result and need for repeat imaging.
RESULTS: During the study period, 124 patients had neuroimaging for suspected cerebrovascular accident, and 119 were MRI safe. Eighty-eight (73.9%) patients underwent DW MRI as first-line investigation. Five patients were not MRI safe and 31 had computed tomography (CT) as first-line imaging due to lack of available MRI capacity. Repeat neuroimaging was performed in 16 (12.9%) patients. Study times were comparable for both types of neuroimaging: a mean of 13 min for MRI and 11 min for CT.
CONCLUSION: The audit standard was achieved in 88 (73.9%) patients. The use of DW MRI as a first-line investigation for patients with a clinical diagnosis of acute stroke is achievable in a district general hospital setting. Copyright 2003 The Royal College of Radiologists

Entities:  

Mesh:

Year:  2003        PMID: 12639530     DOI: 10.1016/s0009-9260(02)00463-4

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  9 in total

1.  Scan immediately for stroke using MRI when possible.

Authors:  Dennis P Briley; Thomas Meagher
Journal:  BMJ       Date:  2004-05-08

2.  Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  P D Schellinger; R N Bryan; L R Caplan; J A Detre; R R Edelman; C Jaigobin; C S Kidwell; J P Mohr; M Sloan; A G Sorensen; S Warach
Journal:  Neurology       Date:  2010-07-13       Impact factor: 9.910

3.  Role of diffusion-weighted MRI in diagnosis of acute renal allograft dysfunction: a prospective preliminary study.

Authors:  M E Abou-El-Ghar; T A El-Diasty; A M El-Assmy; H F Refaie; A F Refaie; M A Ghoneim
Journal:  Br J Radiol       Date:  2012-01-03       Impact factor: 3.039

4.  Importance of b value in diffusion weighted imaging for the diagnosis of pancreatic cancer.

Authors:  Jin-Gang Hao; Jia-Ping Wang; Ya-Lv Gu; Ming-Liang Lu
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

5.  Diffusion weighted magnetic resonance imaging for acute stroke: practical and popular.

Authors:  P L Tan; D King; C J Durkin; T M Meagher; D Briley
Journal:  Postgrad Med J       Date:  2006-04       Impact factor: 2.401

6.  Magnetic resonance brain imaging in patients with acute stroke: feasibility and patient related difficulties.

Authors:  P J Hand; J M Wardlaw; A M Rowat; J A Haisma; R I Lindley; M S Dennis
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11       Impact factor: 10.154

7.  Diffusion-weighted MR imaging of kidneys in patients with chronic kidney disease: initial study.

Authors:  Xueqin Xu; Wenqiang Fang; Huawei Ling; Weimin Chai; Kemin Chen
Journal:  Eur Radiol       Date:  2009-09-30       Impact factor: 5.315

Review 8.  Therapeutic time window of thrombolytic therapy following stroke.

Authors:  Peter D Schellinger; Steven Warach
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

9.  Diffusion-weighted MRI in head and neck radiology: applications in oncology.

Authors:  Harriet C Thoeny
Journal:  Cancer Imaging       Date:  2011-02-03       Impact factor: 3.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.